疾病和决策。

IF 3.7 2区 医学 Q1 PSYCHOLOGY, CLINICAL Journal of Substance Abuse Treatment Pub Date : 2022-11-01 DOI:10.1016/j.jsat.2022.108874
Kirsten E. Smith
{"title":"疾病和决策。","authors":"Kirsten E. Smith","doi":"10.1016/j.jsat.2022.108874","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>At age 16, I injected morphine for the first time, and then started injecting heroin. By most standards, I was highly functioning, although I eventually became addicted. I was and remain socioeconomically privileged, but my relationship to heroin resulted in behaviors and consequences that I never could have conceived of, and which I sometimes strain to remember occurred. My life now is stable and conventional. Some aspects of my past addiction are unerasable, but the most salient of those are the social and legal consequences of having a criminal record—not any hallmarks of a </span>chronic brain disease or disorder. I do not consider myself “in recovery.” Rather, I am recovered, by standards both my own and derived from clinical </span>nosology<span>. I have been in sustained remission for over a decade. Yet feelings are not facts, as is often said. I still use alcohol, and occasionally (though not recently) I have used other drugs<span><span>, so there remains the possibility that my brain is indeed “diseased” and I am not objectively recovered, my self-assessment notwithstanding. My aim in writing about my lived experience of drug use, addiction, and recovery is to highlight the heterogeneity of people's experiences and the insight that personal narratives can provide. Debates about the brain disease model of addiction are often confined to academia, with the real-world, unintended consequences of the “disease” label seldom considered. Stigmatization of people with addiction comes from moralizing about drug use but may also originate from well-intended labels. I posit that we should not need labels to care about addicted people and make scientifically informed </span>treatment<span> accessible. Addicted people deserve help because they either need or want it, regardless of labels that presume to describe the etiology or likely trajectory of their problems. I conclude that some labels, even those needed for clinical classification of human behavior, may be pernicious. Clinicians and researchers have an obligation to reflect more deeply on the implications of the disease conceptualization of complex human behaviors such as addiction.</span></span></span></p></div>","PeriodicalId":17148,"journal":{"name":"Journal of Substance Abuse Treatment","volume":"142 ","pages":"Article 108874"},"PeriodicalIF":3.7000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Disease and decision\",\"authors\":\"Kirsten E. Smith\",\"doi\":\"10.1016/j.jsat.2022.108874\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>At age 16, I injected morphine for the first time, and then started injecting heroin. By most standards, I was highly functioning, although I eventually became addicted. I was and remain socioeconomically privileged, but my relationship to heroin resulted in behaviors and consequences that I never could have conceived of, and which I sometimes strain to remember occurred. My life now is stable and conventional. Some aspects of my past addiction are unerasable, but the most salient of those are the social and legal consequences of having a criminal record—not any hallmarks of a </span>chronic brain disease or disorder. I do not consider myself “in recovery.” Rather, I am recovered, by standards both my own and derived from clinical </span>nosology<span>. I have been in sustained remission for over a decade. Yet feelings are not facts, as is often said. I still use alcohol, and occasionally (though not recently) I have used other drugs<span><span>, so there remains the possibility that my brain is indeed “diseased” and I am not objectively recovered, my self-assessment notwithstanding. My aim in writing about my lived experience of drug use, addiction, and recovery is to highlight the heterogeneity of people's experiences and the insight that personal narratives can provide. Debates about the brain disease model of addiction are often confined to academia, with the real-world, unintended consequences of the “disease” label seldom considered. Stigmatization of people with addiction comes from moralizing about drug use but may also originate from well-intended labels. I posit that we should not need labels to care about addicted people and make scientifically informed </span>treatment<span> accessible. Addicted people deserve help because they either need or want it, regardless of labels that presume to describe the etiology or likely trajectory of their problems. I conclude that some labels, even those needed for clinical classification of human behavior, may be pernicious. Clinicians and researchers have an obligation to reflect more deeply on the implications of the disease conceptualization of complex human behaviors such as addiction.</span></span></span></p></div>\",\"PeriodicalId\":17148,\"journal\":{\"name\":\"Journal of Substance Abuse Treatment\",\"volume\":\"142 \",\"pages\":\"Article 108874\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Substance Abuse Treatment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0740547222001568\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Substance Abuse Treatment","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0740547222001568","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 7

摘要

16岁时,我第一次注射吗啡,然后开始注射海洛因。按照大多数标准,我的机能很好,尽管我最终上瘾了。我过去和现在都享有社会经济特权,但我与海洛因的关系导致了我从未想过的行为和后果,有时我会竭力回忆。我现在的生活是稳定的和传统的。我过去成瘾的某些方面是无法消除的,但其中最突出的是有犯罪记录的社会和法律后果,而不是慢性脑疾病或障碍的任何特征。我并不认为自己“正在康复”。相反,我已经康复了,无论是按照我自己的标准还是根据临床疾病学的标准。十多年来,我一直处于持续缓解状态。然而,正如人们常说的那样,感情并不是事实。我仍然饮酒,偶尔(尽管不是最近)我也使用过其他药物,所以尽管我进行了自我评估,但我的大脑仍有可能确实“生病”,而且我还没有客观地康复。我写吸毒、成瘾和康复的生活经历的目的是强调人们经历的异质性以及个人叙事所能提供的洞察力。关于成瘾的大脑疾病模型的争论通常局限于学术界,很少考虑“疾病”标签在现实世界中的意外后果。对吸毒者的污名化来自于对吸毒的道德说教,但也可能源于善意的标签。我认为,我们不应该需要标签来关心上瘾的人,并让科学知情的治疗变得容易。上瘾的人应该得到帮助,因为他们要么需要帮助,要么想要帮助,不管标签上是用来描述他们问题的病因还是可能的发展轨迹的。我的结论是,一些标签,甚至是人类行为临床分类所需的标签,可能是有害的。临床医生和研究人员有义务更深入地反思成瘾等复杂人类行为对疾病概念化的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Disease and decision

At age 16, I injected morphine for the first time, and then started injecting heroin. By most standards, I was highly functioning, although I eventually became addicted. I was and remain socioeconomically privileged, but my relationship to heroin resulted in behaviors and consequences that I never could have conceived of, and which I sometimes strain to remember occurred. My life now is stable and conventional. Some aspects of my past addiction are unerasable, but the most salient of those are the social and legal consequences of having a criminal record—not any hallmarks of a chronic brain disease or disorder. I do not consider myself “in recovery.” Rather, I am recovered, by standards both my own and derived from clinical nosology. I have been in sustained remission for over a decade. Yet feelings are not facts, as is often said. I still use alcohol, and occasionally (though not recently) I have used other drugs, so there remains the possibility that my brain is indeed “diseased” and I am not objectively recovered, my self-assessment notwithstanding. My aim in writing about my lived experience of drug use, addiction, and recovery is to highlight the heterogeneity of people's experiences and the insight that personal narratives can provide. Debates about the brain disease model of addiction are often confined to academia, with the real-world, unintended consequences of the “disease” label seldom considered. Stigmatization of people with addiction comes from moralizing about drug use but may also originate from well-intended labels. I posit that we should not need labels to care about addicted people and make scientifically informed treatment accessible. Addicted people deserve help because they either need or want it, regardless of labels that presume to describe the etiology or likely trajectory of their problems. I conclude that some labels, even those needed for clinical classification of human behavior, may be pernicious. Clinicians and researchers have an obligation to reflect more deeply on the implications of the disease conceptualization of complex human behaviors such as addiction.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.60
自引率
10.30%
发文量
220
期刊介绍: The Journal of Substance Abuse Treatment (JSAT) features original reviews, training and educational articles, special commentary, and especially research articles that are meaningful to the treatment of alcohol, heroin, marijuana, and other drugs of dependence. JSAT is directed toward treatment practitioners from all disciplines (medicine, nursing, social work, psychology, and counseling) in both private and public sectors, including those involved in schools, health centers, community agencies, correctional facilities, and individual practices. The editors emphasize that JSAT articles should address techniques and treatment approaches that can be used directly by contemporary practitioners.
期刊最新文献
Not in my treatment center: Leadership's perception of barriers to MOUD adoption Peer support to reduce readmission in Medicaid-enrolled adults with substance use disorder National trends in buprenorphine prescribing before and during the COVID-19 pandemic A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations An intervention pilot to facilitate harm reduction service decentralization in Vietnam
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1